515 related articles for article (PubMed ID: 25154562)
1. Are we near to an effective drug treatment for bronchiolitis obliterans?
Verleden GM; Vos R; Dupont L; Van Raemdonck DE; Vanaudenaerde BM; Verleden SE
Expert Opin Pharmacother; 2014 Oct; 15(15):2117-20. PubMed ID: 25154562
[TBL] [Abstract][Full Text] [Related]
2. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
Benden C; Haughton M; Leonard S; Huber LC
J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.
Morrell MR; Despotis GJ; Lublin DM; Patterson GA; Trulock EP; Hachem RR
J Heart Lung Transplant; 2010 Apr; 29(4):424-31. PubMed ID: 19853479
[TBL] [Abstract][Full Text] [Related]
4. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
[TBL] [Abstract][Full Text] [Related]
5. Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation.
O'Hagan AR; Stillwell PC; Arroliga A; Koo A
Chest; 1999 May; 115(5):1459-62. PubMed ID: 10334173
[TBL] [Abstract][Full Text] [Related]
6. Bronchiolitis obliterans syndrome after lung transplantation: medical treatment.
Verleden GM
Monaldi Arch Chest Dis; 2000 Apr; 55(2):140-5. PubMed ID: 10949876
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Pecoraro Y; Carillo C; Diso D; Mantovani S; Cimino G; De Giacomo T; Troiani P; Shafii M; Gherzi L; Amore D; Rendina EA; Venuta F; Anile M
Transplant Proc; 2017 May; 49(4):695-698. PubMed ID: 28457374
[TBL] [Abstract][Full Text] [Related]
8. Bronchiolitis obliterans syndrome is not specific for bronchiolitis obliterans in pediatric lung transplant.
Towe C; Chester Ogborn A; Ferkol T; Sweet S; Huddleston C; White F; Faro A
J Heart Lung Transplant; 2015 Apr; 34(4):516-21. PubMed ID: 25499141
[TBL] [Abstract][Full Text] [Related]
9. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
[TBL] [Abstract][Full Text] [Related]
10. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
[TBL] [Abstract][Full Text] [Related]
11. Bronchiolitis obliterans following lung transplantation.
Al-Githmi I; Batawil N; Shigemura N; Hsin M; Lee TW; He GW; Yim A
Eur J Cardiothorac Surg; 2006 Dec; 30(6):846-51. PubMed ID: 17055283
[TBL] [Abstract][Full Text] [Related]
12. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal Photopheresis for Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Hachem R; Corris P
Transplantation; 2018 Jul; 102(7):1059-1065. PubMed ID: 29557913
[TBL] [Abstract][Full Text] [Related]
14. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience.
Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W
Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1 is a useful biomarker for early detection of bronchiolitis obliterans in lung transplant recipients.
Salama M; Jaksch P; Andrukhova O; Taghavi S; Klepetko W; Aharinejad S
J Thorac Cardiovasc Surg; 2010 Dec; 140(6):1422-7. PubMed ID: 21078427
[TBL] [Abstract][Full Text] [Related]
16. Pathologic correlates of bronchiolitis obliterans syndrome in pulmonary retransplant recipients.
Martinu T; Howell DN; Davis RD; Steele MP; Palmer SM
Chest; 2006 Apr; 129(4):1016-23. PubMed ID: 16608952
[TBL] [Abstract][Full Text] [Related]
17. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
Verleden GM; Dupont LJ; Van Raemdonck DE
Eur Respir J; 2005 Feb; 25(2):221-4. PubMed ID: 15684284
[TBL] [Abstract][Full Text] [Related]
18. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
[TBL] [Abstract][Full Text] [Related]
19. Advances in Understanding Bronchiolitis Obliterans After Lung Transplantation.
Verleden SE; Sacreas A; Vos R; Vanaudenaerde BM; Verleden GM
Chest; 2016 Jul; 150(1):219-25. PubMed ID: 27212132
[TBL] [Abstract][Full Text] [Related]
20. Managing bronchiolitis obliterans syndrome (BOS) and chronic lung allograft dysfunction (CLAD) in children: what does the future hold?
Snell GI; Paraskeva M; Westall GP
Paediatr Drugs; 2013 Aug; 15(4):281-9. PubMed ID: 23605986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
